Study from American Society of Hematology on COVID-19 Vaccine

The American Society of Hematology has released a study, Low Neutralizing Antibody Responses Against SARS-CoV-2 in Elderly Myeloma Patients After the First BNT162b2 Vaccine Dose. This study supports the results of a recent UK study, encouraging manufacturer’s recommendations for vaccination timing be followed in cancer patients.